Literature DB >> 16434209

Variation in expression of gastric leptin according to differentiation and growth pattern in gastric adenocarcinoma.

Su Jin Hong1, Kye Won Kwon, Sang Gyune Kim, Bong Min Ko, Chang Beom Ryu, Young Seok Kim, Jong Ho Moon, Joo Young Cho, Joon Seong Lee, Moon Sung Lee, Chan Sup Shim, Boo Sung Kim.   

Abstract

Leptin is an adipocyte-derived hormone that regulates body fat stores and feeding behavior. The presence of leptin in stomach epithelium was recently demonstrated in the rat and humans, and gastric leptin has been linked to the control of meal size, local inflammatory responses, and paracrine and autocrine functions through leptin receptors in the stomach. We compared the expression patterns of leptin and of the long variant of the leptin receptor (Ob-Rb) between areas with non-ulcerated mucosa and with hyperplastic polyps, adenoma, or adenocarcinoma to evaluate the expression relative to different disease states. Leptin and Ob-Rb were expressed in hyperplastic polyps, adenoma, and adenocarcinoma. In the gastric adenocarcinoma, leptin was expressed significantly less in the poorly differentiated and diffuse-type groups than in the well-differentiated and moderately differentiated groups or in the intestinal type. Based upon our findings, we suggest the possibility that leptin expression can have a pathophysiologic role about the differentiation or growth pattern of gastric adenocarcinoma. A further series of experiments is necessary to elucidate the pathophysiological role of leptin in the differentiation of gastric adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16434209     DOI: 10.1016/j.cyto.2005.11.015

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  9 in total

1.  Decreased body fat and gastric cancer: does the hen come before the egg, or vice versa?

Authors:  Peter Gunvén
Journal:  Gastric Cancer       Date:  2008       Impact factor: 7.370

2.  Expression and clinical significance of leptin, the functional receptor of leptin (OB-Rb) and HER-2 in non-small-cell lung cancer: a retrospective analysis.

Authors:  Yan-Jie Xu; Yong-Feng Shao; Xia Zhao; Yi-Ting Geng; Kai Wang; Yong-Mei Yin
Journal:  J Cancer Res Clin Oncol       Date:  2011-09-17       Impact factor: 4.553

Review 3.  Diverse roles of leptin in the gastrointestinal tract: modulation of motility, absorption, growth, and inflammation.

Authors:  Shadi S Yarandi; Gautam Hebbar; Cary G Sauer; Conrad R Cole; Thomas R Ziegler
Journal:  Nutrition       Date:  2010-10-13       Impact factor: 4.008

4.  Overexpression of the obesity hormone leptin in human colorectal cancer.

Authors:  Mariusz Koda; Mariola Sulkowska; Luiza Kanczuga-Koda; Eva Surmacz; Stanislaw Sulkowski
Journal:  J Clin Pathol       Date:  2007-08       Impact factor: 3.411

5.  Leptin: a correlated Peptide to papillary thyroid carcinoma?

Authors:  Mehdi Hedayati; Parichehr Yaghmaei; Zahra Pooyamanesh; Marjan Zarif Yeganeh; Laleh Hoghooghi Rad
Journal:  J Thyroid Res       Date:  2011-10-05

6.  Serum leptin levels in gastric cancer patients and the relationship with insulin resistance.

Authors:  Huseyin Begenik; Mehmet Aslan; Ahmet Cumhur Dulger; Habib Emre; Ahu Kemik; Ozgur Kemik; Ramazan Esen
Journal:  Arch Med Sci       Date:  2015-04-23       Impact factor: 3.318

7.  Leptin-LepRb Expressed in Gastric Cancer Patients and Related to Cancer-Related Depression.

Authors:  Yunbao Pan; Fuling Zhou; Chenyan He; Lingyun Hui; Tianhe Huang; Yongchang Wei
Journal:  Biomed Res Int       Date:  2017-02-20       Impact factor: 3.411

8.  Expression of leptin and leptin receptors in colorectal cancer-an immunohistochemical study.

Authors:  Saad M Al-Shibli; Shaikh Mizan; Norra Harun; Abdelkader E Ashour; Mohd Hanif B Mohd Kasmuri
Journal:  PeerJ       Date:  2019-10-02       Impact factor: 2.984

9.  Overexpression of leptin receptor predicts an unfavorable outcome in Middle Eastern ovarian cancer.

Authors:  Shahab Uddin; Rong Bu; Maqbool Ahmed; Jehad Abubaker; Fouad Al-Dayel; Prashant Bavi; Khawla S Al-Kuraya
Journal:  Mol Cancer       Date:  2009-09-18       Impact factor: 27.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.